Articles by Ben Comer - Pharmaceutical Executive

ADVERTISEMENT

Articles by Ben Comer

From Locked Box to Data Sphere

Jun 1, 2013

Project Data Sphere aims to liberate clinical trial data sets from industry and academic vaults, in an attempt to catalyze cancer research and discovery.

Regeneron: New York State of Mind

Jun 1, 2013

Led by two New Yorkers with a mindset that marries novel scientific insights to the processing power of novel technologies, Regeneron's success is a revolutionary challenge to the industry status quo.

Whistling Past the Graveyard

May 1, 2013

A night of comedy in support of a chronic disease.

Conflicted Interest

Apr 1, 2013

Do Big Pharma dollars make physicians lousy caregivers?

Brand of the Year: Januvia

Mar 1, 2013

In 2012, Merck's diabetes franchise became the highest-selling product family in its 122-year history.

NHTSA Addresses "Drugged Driving"

Feb 1, 2013

After years of asking questions, the National Highway Traffic Safety Administration (NHTSA)is moving closer to a protocol "for assessing the driving-impairment risks of drugs". Ben Comer reports.

Compliance in the C-Suite

Jan 1, 2013

Compliance officers have risen into management's highest ranks, by choice in some organizations, and by government decree in others. Either way, their importance as a strategic partner can hardly be understated.

Top Medical Innovations for 2013

Dec 1, 2012

Ben Comer profiles 10 innovative technologies designated as new and revolutionary tools for the treatment of disease and disability.

Pharm Exec's 2013 Pipeline Report

Nov 1, 2012

Is the 'lost decade' of declining pipeline productivity finally over? Our annual survey of analyst assessments of the state of drug development suggests so...

ADVERTISEMENT

Click here